251 related articles for article (PubMed ID: 19577687)
1. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Feeman WE
Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577687
[No Abstract] [Full Text] [Related]
2. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
de Tena JG
Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577686
[No Abstract] [Full Text] [Related]
3. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Danchin N
Lancet; 2009 Jul; 374(9683):24-5; author reply 26-7. PubMed ID: 19577685
[No Abstract] [Full Text] [Related]
4. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Sniderman AD
Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690
[No Abstract] [Full Text] [Related]
5. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Rosenstein R; Parra D
Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577689
[No Abstract] [Full Text] [Related]
6. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Bloom JM
Lancet; 2009 Jul; 374(9683):25-6; author reply 26-7. PubMed ID: 19577688
[No Abstract] [Full Text] [Related]
7. The JUPITER Trial: responding to the critics.
Ridker PM; Glynn RJ
Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
[No Abstract] [Full Text] [Related]
8. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
Segura J; Ruilope LM
Lancet; 2009 Jul; 374(9683):26; author reply 26-7. PubMed ID: 19577691
[No Abstract] [Full Text] [Related]
9. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
[TBL] [Abstract][Full Text] [Related]
10. Rosuvastatin in patients with elevated C-reactive protein.
Jenny-Avital ER
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
[No Abstract] [Full Text] [Related]
11. [JUPITER: reduction by rosuvastatin of cardiovascular events and mortality in healthy subjects without hyperlipidaemia but with elevated C-reactive protein].
Scheen AJ
Rev Med Liege; 2008 Dec; 63(12):749-53. PubMed ID: 19180837
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin in patients with elevated C-reactive protein.
Chan PS; Nallamothu BK; Hayward RA
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
[No Abstract] [Full Text] [Related]
13. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
[No Abstract] [Full Text] [Related]
14. JUPITER strikes earth.
Fuster V; Bansilal S
Nat Clin Pract Cardiovasc Med; 2009 Mar; 6(3):159. PubMed ID: 19234496
[No Abstract] [Full Text] [Related]
15. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
[No Abstract] [Full Text] [Related]
16. JUPITER, rosuvastatin, and the European Medicines Agency.
Ridker PM; Glynn RJ
Lancet; 2010 Jun; 375(9731):2071. PubMed ID: 20494436
[No Abstract] [Full Text] [Related]
17. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Ridker PM;
Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
[No Abstract] [Full Text] [Related]
18. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
Lubsen J
Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
[No Abstract] [Full Text] [Related]
19. Bringing JUPITER down to earth.
Després JP
Lancet; 2009 Apr; 373(9670):1147-8. PubMed ID: 19329179
[No Abstract] [Full Text] [Related]
20. Rosuvastatin and the JUPITER trial: critical appraisal of a lifeless planet in the galaxy of primary prevention.
López A; Wright JM
Int J Occup Environ Health; 2012; 18(1):70-8. PubMed ID: 22550699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]